Paulson Wealth Management Inc. Has $2.08 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Paulson Wealth Management Inc. lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,551 shares of the healthcare conglomerate’s stock after selling 50 shares during the quarter. UnitedHealth Group accounts for about 0.6% of Paulson Wealth Management Inc.’s investment portfolio, making the stock its 28th biggest holding. Paulson Wealth Management Inc.’s holdings in UnitedHealth Group were worth $2,076,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Tealwood Asset Management Inc. bought a new position in UnitedHealth Group in the third quarter valued at approximately $2,905,000. Asset Planning Services Inc. LA ADV lifted its position in UnitedHealth Group by 1.2% in the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after acquiring an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of UnitedHealth Group by 13.7% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after purchasing an additional 3,006 shares during the period. Americana Partners LLC boosted its position in shares of UnitedHealth Group by 10.8% during the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after buying an additional 1,984 shares during the period. Finally, Hennion & Walsh Asset Management Inc. raised its position in UnitedHealth Group by 14.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after buying an additional 1,283 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Stephens reduced their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Morgan Stanley dropped their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Argus boosted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Down 1.6 %

UNH stock opened at $615.01 on Wednesday. The business’s fifty day moving average price is $582.63 and its two-hundred day moving average price is $546.78. The stock has a market capitalization of $565.98 billion, a price-to-earnings ratio of 40.07, a PEG ratio of 1.84 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.56 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.